A treatment that kills Corona in 5 days?!

The president of South Korean pharmaceutical company, Celtion, “Seo Jung-jin”, said his company will apply for an emergency use permit to treat the emerging coronavirus, which is being developed by the Ministry of Food Safety and drugs next month.

The company announced “CT-P59”, which is a monoclonal antibody treatment against Covid-19, and reduces patient recovery times without reporting any side effects.

The treatment is currently undergoing a second phase of clinical trials, after the successful completion of the first phase on healthy volunteers who did not have the virus, according to the Korean agency Yonhap.

He also said the drug kills Coronavirus within 4-5 days, which effectively protects patients with mild symptoms from developing a serious condition.

“Celterion is currently completing the second phase of the clinical trial for antibody therapy and we will make every effort to obtain conditional clearance from the Ministry of Food and Drug Safety by the end of the year,” said Celterion Group President.